161 results on '"Montserrat, Emili’"'
Search Results
2. International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia
3. Minimal Residual Disease and Survival Outcomes in Patients With Chronic Lymphocytic Leukemia: A Systematic Review and Meta-analysis
4. High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies
5. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
6. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
7. Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation
8. Treatment of Chronic Lymphocytic Leukemia With del(17p)/TP53 Mutation: Allogeneic Hematopoietic Stem Cell Transplantation or BCR-Signaling Inhibitors?
9. Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?
10. Rituximab-Based Chemoimmunotherapy Prolongs Survival of Patients With Chronic Lymphocytic Leukemia Independently of the Time of Administration
11. Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia
12. Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signaling
13. Thrombotic and Bleeding Complications in Patients with Chronic Lymphocytic Leukemia and Severe COVID-19: A Study of Eric, the European Research Initiative on CLL
14. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project
15. Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance
16. Chronic Lymphocytic Leukemia: New Concepts for Future Therapy
17. Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma
18. Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clínic of Barcelona experience
19. Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM
20. Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation
21. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
22. MicroRNA expression profiling in classic Hodgkin lymphoma
23. Anemia Associated with Impaired Erythropoietin Secretion after Allogeneic Stem Cell Transplantation: Incidence, Risk Factors, and Response to Treatment
24. Worldwide Examination of Patients with CLL Hospitalized for COVID-19
25. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations
26. High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma
27. Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia
28. Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemia
29. How I treat refractory CLL
30. Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia
31. Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation
32. The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status
33. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction
34. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene
35. Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation
36. Follicular Lymphoma International Prognostic Index
37. Role of auto- and allotransplantation in B-cell chronic lymphocytic leukemia
38. Nuclear Survivin Expression in Mantle Cell Lymphoma Is Associated with Cell Proliferation and Survival
39. Mechanism of action and resistance to monoclonal antibody therapy
40. Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia
41. Rituximab in chronic lymphocytic leukemia
42. Low-dose total-body irradiation and fludarabine followed by hematopoietic cell transplantation from HLA-identical sibling donors do not induce complete T-cell donor engraftment in most patients with progressive hematologic diseases
43. High levels of chromosomal imbalances in typical and small-cell variants of T-cell prolymphocytic leukemia
44. Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?
45. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma
46. Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia
47. CD34 +-enriched–CD19 +-depleted autologous peripheral blood stem cell transplantation for chronic lymphoproliferative disorders : High purging efficiency but increased risk of severe infections
48. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances
49. Genetic Imbalances in Progressed B-Cell Chronic Lymphocytic Leukemia and Transformed Large-Cell Lymphoma (Richter's Syndrome)
50. Prognostic and Predictive Markers in CLL
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.